v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 23,170 $ 25,000
Cost of goods sold 7,385 2,909
Gross profit 15,785 22,091
Operating Expenses:    
Research and development 1,926,311 2,646,900
General and administrative 1,475,207 2,182,725
Total Operating Expenses 3,401,518 4,829,625
Loss From Operations (3,385,733) (4,807,534)
Other Income (Expense):    
Dividend and interest income, net 5,479 100,608
Other income 5,728 1,246
Change in fair value of warrant liabilities 1,220,121 (634,119)
Total Other Income (Expense) 1,231,328 (532,265)
Net Loss $ (2,154,405) $ (5,339,799)
Net Loss Per Share - Basic $ (0.12) $ (0.64)
Net Loss Per Share - Diluted $ (0.12) $ (0.64)
Weighted Average Common Shares Outstanding - Basic 17,727,747 8,357,143
Weighted Average Common Shares Outstanding - Diluted 17,727,747 8,357,143

Source